Skip to main content
OpenTrials

Clinical trial condition

Plaque Psoriasis

Explore clinical trials studying Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

295 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Plaque Psoriasis trial results

Completed

Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis

NCT01777191

Conditions
Plaque Psoriasis
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anaheim, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bakersfield, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santa Monica, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States
View all 25 locations
View Trial Details
Completed

A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.

NCT02752776

Conditions
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, +6 more
Locations
  • Novartis Investigative Site Geel, BEL, Belgium
  • Novartis Investigative Site Bruges, Belgium
  • Novartis Investigative Site Ghent, Belgium
  • Novartis Investigative Site Seraing, Belgium
View all 215 locations
View Trial Details
Completed

Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis

NCT02826603

Conditions
Plaque Psoriasis
Locations
  • Novartis Investigative Site Anniston, Alabama, United States
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Mobile, Alabama, United States
View all 154 locations
View Trial Details
Completed

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)

NCT02134210

Conditions
Plaque Psoriasis
Locations
  • Arizona Research Center Phoenix, Arizona, United States
  • Radiant Research - Scottsdale Scottsdale, Arizona, United States
  • Anaheim Clinical Trials Anaheim, California, United States
  • Dream Team Clinical Research Anaheim, California, United States
View all 100 locations
View Trial Details
Completed

A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.

NCT02486302

Conditions
Ankylosis, Arthritis, Arthritis, Psoriatic, +20 more
Locations
  • Rheumatologisches MVZ Dresden GmbH im Gesundheitszentrum Dresden - Klotzsche (GZDK) Dresden, Saxony, Germany
  • private practise Hemmerich Aachen, Germany
  • private practise Kurthen Aachen, Germany
  • Gesundheits- und Pflegezentrum Alsfeld gGmbH Alsfeld, Germany
View all 180 locations
View Trial Details
Completed

Plaque Psoriasis Efficacy and Safety With Secukinumab

NCT02409667

Conditions
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, +5 more
Locations
  • Novartis Investigative Site Innsbruck, Austria
  • Novartis Investigative Site Linz, Austria
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Vienna, Austria
View all 200 locations
View Trial Details

Related conditions